📰 Pro Dex News
Page 5 - Pro Dex News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pro Dex. Real-time updates on events, politics, business and more.
May 3, 2023
StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a research note issued to investors on Sunday morning. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Price Performance Shares of NASDAQ PDEX opened at $15.69 on Friday. The company has a fifty day moving average price of […]
April 26, 2023
StockNews.com started coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report published on Saturday morning. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Trading Down 1.8 % Shares of Pro-Dex stock opened at $15.95 on Friday. The company’s fifty day simple moving average is $16.41 and its […]
April 19, 2023
Pro-Dex (NASDAQ:PDEX – Get Rating) and Sensus Healthcare (NASDAQ:SRTS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability. Institutional & Insider Ownership 13.5% of Pro-Dex shares are held […]
April 16, 2023
Equities researchers at StockNews.com began coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report issued on Friday. The firm set a “buy” rating on the medical instruments supplier’s stock. Pro-Dex Stock Down 2.3 % Shares of PDEX opened at $16.30 on Friday. Pro-Dex has a one year low of $12.40 and a […]
April 16, 2023
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 11,300 shares, a decline of 20.4% from the March 15th total of 14,200 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average trading volume […]
April 3, 2023
Pro-Dex (NASDAQ:PDEX – Get Rating) and Cytosorbents (NASDAQ:CTSO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings. Risk and Volatility Pro-Dex has a beta of 0.99, meaning that […]
April 2, 2023
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 14,200 shares, a growth of 20.3% from the February 28th total of 11,800 shares. Approximately 0.6% of the company’s stock are short sold. Based on an average daily […]
April 2, 2023
StockNews.com assumed coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report issued on Wednesday morning. The brokerage issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Trading Down 1.2 % Shares of PDEX stock opened at $16.41 on Wednesday. The stock has a market cap of $58.09 million, a price-to-earnings […]
April 2, 2023
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 14,200 shares, a growth of 20.3% from the February 28th total of 11,800 shares. Approximately 0.6% of the company’s shares are short sold. Based on […]
April 1, 2023
StockNews.com began coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a research report sent to investors on Wednesday. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Price Performance NASDAQ PDEX opened at $16.41 on Wednesday. The stock has a market capitalization of $58.09 million, a P/E ratio of […]